Kinsa Health announced the availability of the Kinsa Smart Thermometer, the first FDA-cleared smartphone-connected thermometer and health tracking app.
Navidea announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Lymphoseek (technetium Tc 99m tilmanocept) injection.
The Food and Drug Administration (FDA) has approved Lumason (sulfur hexafluoride lipid microsphere; Bracco Diagnostics) for patients whose echocardiograms are difficult to see with ultrasound waves.
A magnetic resonance imaging (MRI) scan that measures blood flow in the brain may help predict which older adults are at risk for future memory loss.
Researchers have found it's possible to detect ovarian cancer gene mutations in vaginal fluid samples – a finding they hope is a step toward an effective screening test for the disease.
Exosomes were once dismissed and referred to as “cell dust,” but researchers believe these biomarkers may potentially help detect early-stage lung cancers.
T2 Biosystems announced that it has received marketing clearance from the Food and Drug Administration (FDA) for their T2Candida Panel and T2Dx Instrument, the first blood test for the direct detection of Candida species in human whole blood specimens from patients with symptoms of, or medical conditions predisposing the patient to, invasive fungal infections.
Review this chart for quick information when you need it.